Improving access to treatment for substance use disorders
Addressing Barriers to Care for Substance Use Disorder Trial (Center for Dissemination and Implementation At Stanford, Research Component #3)
This study is testing if having care coordinators help patients find and stick with treatment for substance use disorders makes a difference in getting more people to engage in their care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 360 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Kaiser Permanente Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT06729957 on ClinicalTrials.gov |
What this trial studies
The Addressing Barriers to Care for Substance Use Disorder Trial evaluates the effectiveness of care navigation in enhancing patient engagement in treatment for substance use disorders. Conducted at a mental health access center within Kaiser Permanente in Washington, the trial employs a cluster-randomized crossover design where care coordinators alternate between standard services and the care navigation intervention. Patients seeking treatment will interact with care coordinators who will either provide usual care or enhanced navigation support, with the goal of increasing treatment uptake. The study will analyze outcomes based on the assigned intervention arm, regardless of patient participation in care navigation.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older seeking treatment for substance use disorders through the mental health access center.
Not a fit: Patients who have opted out of research contact or are not enrolled in Kaiser Permanente or Medicaid may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve patient engagement in treatment for substance use disorders.
How similar studies have performed: Other studies have shown promise in using care navigation to improve treatment engagement for substance use disorders, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Clinician (Care Coordinator) Inclusion Criteria: * Conducts assessment and treatment planning visits in the mental health access center * Has been employed for at least 1 month * Has completed trainings related to their clinical role in the health system * Scheduled to conduct assessments Clinician Exclusion Criteria: None Patient Inclusion Criteria (eligibility for analyses): * Visits an enrolled care coordinator during the patient eligibility period * ≥ 18 years of age at the time of the visit * Has an assessment and treatment planning visit for SUD with an enrolled care coordinator Patient Exclusion Criteria: * Patients who have requested through the health system to opt out of research contact or chart review * Patients who are not enrolled in Kaiser Permanente or Medicaid insurance (anticipated incomplete capture of covariate and/or outcome information)
Where this trial is running
Seattle, Washington
- Kaiser Permanente Washington — Seattle, Washington, United States (Recruiting)
Study contacts
- Principal investigator: Joseph E Glass, PhD, MSW — Chestnut Health Systems
- Study coordinator: Tara Beatty, MA
- Email: Tara.C.Beatty@kp.org
- Phone: 206-442-4012
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.